Humana (HUM) Competitors

Elevance Health (NYSE:ELV) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, community ranking, profitability, dividends, earnings and media sentiment.

Do institutionals & insiders believe in ELV or HUM?

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 0.4% of Humana shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Do analysts rate ELV or HUM?

Elevance Health currently has a consensus target price of $510.38, suggesting a potential upside of 23.73%. Humana has a consensus target price of $286.81, suggesting a potential upside of 12.37%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.76
Humana	0 Sell rating(s)	17 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.29

Which has stronger valuation and earnings, ELV or HUM?

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$183.12B	0.51	$5.98B	$25.63	16.09
Humana	$120.26B	0.26	$1.21B	$14.14	18.05

Which has more volatility & risk, ELV or HUM?

Elevance Health has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500.

Is ELV or HUM a better dividend stock?

Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 1.7%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.4%. Elevance Health pays out 26.7% of its earnings in the form of a dividend. Humana pays out 25.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Does the MarketBeat Community prefer ELV or HUM?

Humana received 21 more outperform votes than Elevance Health when rated by MarketBeat users. However, 67.23% of users gave Elevance Health an outperform vote while only 62.57% of users gave Humana an outperform vote.

Company	Underperform	Outperform
Elevance Health	Outperform Votes 880 67.23%	Underperform Votes 429 32.77%
Humana	Outperform Votes 901 62.57%	Underperform Votes 539 37.43%

Is ELV or HUM more profitable?

Elevance Health has a net margin of 3.38% compared to Humana's net margin of 1.02%. Elevance Health's return on equity of 18.28% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	3.38%	18.28%	6.72%
Humana	1.02%	11.70%	3.99%

Does the media refer more to ELV or HUM?

In the previous week, Elevance Health had 30 more articles in the media than Humana. MarketBeat recorded 62 mentions for Elevance Health and 32 mentions for Humana. Humana's average media sentiment score of 0.94 beat Elevance Health's score of 0.78 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	31 Very Positive mention(s)	2 Positive mention(s)	25 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Positive
Humana	17 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Elevance Health beats Humana on 15 of the 21 factors compared between the two stocks.